SCHEMBL6807218

SCHEMBL6807218

COc1ccc(-c2ccccc2C(OC)OC)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.55
ABCB1 P08183 2/20 0.55
BCR P11274 2/20 0.55
HDAC4 P56524 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
PTPN1 P18031 1/20 0.47
MAPT P10636 5/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
BACE1 P56817 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HTR1A P08908 1/20 0.43
HTR7 P34969 1/20 0.43
MITF O75030 1/20 0.42
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1210873 0.84 ALDH1A1 (0.41) ABL1ABCB1BCRMAPTRAB9A
SCHEMBL13913541 0.83 ABL1 (0.56) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL6258936 0.80 MAPT (0.48) PTPN1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL12715050 0.80 ABL1 (0.79) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL27613425 0.79 ABL1 (0.51) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL11096260 0.78 ABL1 (0.76) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL11996556 0.77 ABCB1 (0.50) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL8972805 0.77 ABL1 (0.50) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL31376566 0.77 ABL1 (0.50) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL3253571 0.76 ABL1 (0.49) ABL1ABCB1BCRHDAC4HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040018598-A1 Bio-intermediates for use in the chemical synthesis of polyketides SANTI DANIEL (US) 2004-01-29 US disclosed
EP-1307579-A2 BIO-INTERMEDIATES FOR USE IN THE CHEMICAL SYNTHESIS OF POLYKETIDES Kosan Biosciences, Inc. (US) 2003-05-07 EP disclosed
US-20020052028-A1 Bio-intermediates for use in the chemical synthesis of polyketides KOSAN BIOSCIENCES, INC. 2002-05-02 US disclosed
WO-2002012534-A2 BIO-INTERMEDIATES FOR USE IN THE CHEMICAL SYNTHESIS OF POLYKETIDES KOSAN BIOSCIENCES, INC. (US) 2002-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040018598-A1 Bio-intermediates for use in the chemical synthesis of polyketides DHPS, FDFT1, COASY ABL1 4748/4885ABCB1 1736/4885BCR 2016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.